We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01666717
Recruitment Status : Completed
First Posted : August 16, 2012
Last Update Posted : August 17, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel Disease(IBD) patients versus healthy controls (HC).

Condition or disease
Inflammatory Bowel Diseases

Study Design

Study Type : Observational
Actual Enrollment : 204 participants
Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling
Study Start Date : August 2008
Study Completion Date : May 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bowel Movement
U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Healthy controls (HC)
HC
Inflammatory Bowel Disease (IBD) patients
Crohn's disease (CD), Ulcerative colitis (UC) and pouchitis


Outcome Measures

Biospecimen Retention:   Samples With DNA
Fecal samples

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Primary care clinic
Criteria

Inclusion Criteria:

  • Clinical diagnosis of IBD
  • Age >18 years

Exclusion Criteria:

  • Use of antibiotics in the preceding month
  • Intake of pre- or probiotics
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01666717


Locations
Belgium
KULeuven-UZLeuven
Leuven, Vlaams-Brabant, Belgium, 3000
Sponsors and Collaborators
Katholieke Universiteit Leuven
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Kristin Verbeke, Professor K. Verbeke, Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier: NCT01666717     History of Changes
Other Study ID Numbers: ML4355_VOC
First Posted: August 16, 2012    Key Record Dates
Last Update Posted: August 17, 2012
Last Verified: August 2012

Additional relevant MeSH terms:
Intestinal Diseases
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Gastroenteritis